Skip to main content
Erschienen in:

01.06.2019 | Case report

Bortezomib, dexamethasone and lenalidomide

Syndrome of inappropriate secretion of antidiuretic hormone: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Baba Y, et al. Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy. Rinsho Ketsueki 59: 2423-2427, No. 11, 2018. Available from: URL: http://doi.org/10.11406/rinketsu.59.2423 [Japanese;summarised from a translation] - Japan Baba Y, et al. Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy. Rinsho Ketsueki 59: 2423-2427, No. 11, 2018. Available from: URL: http://​doi.​org/​10.​11406/​rinketsu.​59.​2423 [Japanese;summarised from a translation] - Japan
Metadaten
Titel
Bortezomib, dexamethasone and lenalidomide
Syndrome of inappropriate secretion of antidiuretic hormone: case report
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63627-6